3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Polycystic Ovary Syndrome
14
Breast Neoplasms
11
Prostatic Neoplasms
9
Obesity
7
Insulin Resistance
6
Carcinoma, Non-Small-Cell Lung
5
Lung Neoplasms
4
Colorectal Neoplasms
4
Motor Activity
3
Adenocarcinoma of Lung
3
Squamous Cell Carcinoma of Head and Neck
2
Pancreatic Neoplasms
2
Neoplasms
2
Menstruation Disturbances
2
Lymphoma, Large B-Cell, Diffuse
2
Head and Neck Neoplasms
2
Endometrial Neoplasms
2
Diabetes Mellitus
2
Weight Loss
1
Urothelial Cancer
1
Thyroid Diseases
1
Thoracic Neoplasms
1
Smoldering Multiple Myeloma
1
Rectal Neoplasms
1
Prediabetic State
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pleural Effusion, Malignant
1
Overweight
1
Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
1
Non-alcoholic Fatty Liver Disease
1
Interventions
temsirolimus
1
sargramostim
1
ruxolitinib
1
rucaparib
1
pazopanib
1
olaparib
1
eltrombopag
1
cc-486
1
Surveys and Questionnaires
1
Nivolumab
1
Monatide (IMS 3015)
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Doxorubicin
1
Docetaxel
1
Diphenhydramine
1
Cytarabine
1
Cyclophosphamide
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Pathologic Complete Response
×
Metformin
×
Clear all
No trials found.